Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William J. Wood is active.

Publication


Featured researches published by William J. Wood.


Ophthalmology | 1997

Vision-threatening Complications of Surgery for Full-thickness Macular Holes

Alay S. Banker; William R. Freeman; Jung V. Kim; David Munguia; Stanley P. Azen; Jung W. Kim; Mei-Ying Lai; Gary W. Abrams; Rabbi Wayne Dosick; Sandy T. Feldman; Renata Ochabski; Stuart L. Fine; Ian L. Bailey; Thomas M. Aaberg; Brian B. Berger; George W. Blankenship; Alexander J. Brucker; Serge de Bustros; Akitoshi Yoshida; Howard D. Gilbert; Dennis P. Han; Gregg T. Kokame; Brooks W. McCuen; Donald A. Frambach; Joseph Olk; Jack O. Sipperley; Van W. Teeters; William J. Wood

OBJECTIVE To study complications of vitrectomy surgery for full-thickness macular holes. DESIGN A multicentered, randomized, controlled clinical trial. PARTICIPANTS Community and university-based ophthalmology clinics. INTERVENTION Standardized macular hole surgery versus observation. MAIN OUTCOME MEASURES Assessment of anatomic and visual outcomes and determination of postoperative complications at 12 months after randomization. RESULTS Posterior segment complications were noted in 39 eyes (41%). The incidence of retinal pigment epithelium (RPE) alteration and retinal detachment (RD) were 33% and 11%, respectively. One RD due to a giant retinal tear resulted in a visual acuity of light perception. Other complications included a reopening of the macular hole in 2 eyes (2%), cystoid macular edema in 1 eye (1%), a choroidal neovascular membrane in 1 eye (1%) and endophthalmitis in 1 eye (1%). Eyes with complications had significantly worse visual acuity outcomes as determined by the Early Treatment Diabetic Retinopathy Study, Word Reading, and Potential Acuity Meter charts (P < 0.01 for all comparisons). Eyes with macular holes greater than 475 microns were more than twice as likely to have complications than eyes with holes less than 475 microns (odds ratio [OR] = 2.2, P = 0.07). Before surgery, the stage of the hole was related to postoperative RPE changes (P < 0.0001) and the occurrence of postoperative RD (P = 0.0002). Intraoperative trauma was related to the occurrence of these complications (P < 0.0001 for RPE changes, P = 0.02 for RDs). Epiretinal membrane removal was related to RPE changes (P = 0.02) but not RDs. CONCLUSIONS The RPE alterations and RDs are common after macular hole surgery and result in significantly reduced postoperative visual acuity. The RPE changes may be related to surgical trauma or light toxicity. Further efforts to reduce complications associated with macular hole surgery are indicated.


Ophthalmology | 1994

Vitrectomy for Prevention of Macular Holes: Results of a Randomized Multicenter Clinical Trial

Serge de Bustros; Thomas M. Aaberg; Paul Sternberg; Bert M. Glaser; Ronald G. Michels; Thomas A. Rice; Brooks W. Mc Cuen; William J. Wood; Rick D. Isernhagen; Patrick J. Murphy; H. Richard McDonald; Robert N. Johnson; Howard Schatz; R. Joseph Olk; M. Gilbert Grand; David R. Williams; Gregg T. Kokame; Jack O. Sipperley; Howard D. Gilbert; Bruce R Garretson; Kirk H. Packo; Brian B. Berger; Cheryl Enger; William D. Freeman; Maureen G. Maguire; Andrew P. Schachat

PURPOSE: The purpose of this study is to assess the benefit of vitreous surgery in preventing full-thickness macular holes in patients with impending (stage 1) macular holes. METHODS: A prospective randomized multicenter clinical trial was conducted on patients with full-thickness macular holes in their first eye (stage 3 or 4) and signs and symptoms of stage 1 macular holes in their fellow eye (study eye). The study eye was randomized to vitreous surgery or observation. Outcome was assessed by standardized measurement of visual acuity, detailed clinical examination, fundus photographs, and fluorescein angiography. RESULTS: A full-thickness macular hole developed in 10 (37%) of 27 patients in the vitrectomy group compared with 14 (40%) of 35 patients randomized to observation (P = 0.81). This difference of 3% has a 95% confidence interval of (-21%, 27%). CONCLUSION: The study was terminated because of low recruitment. The authors were unable to prove (or disprove) the benefit of vitreous surgery in patients with stage 1 macular holes. The authors can state, however, that should a beneficial effect from vitrectomy exist, it would probably be minimal. Considering the cost and morbidity of vitreous surgery, a conservative approach for stage 1 macular hole might be appropriate.Purpose: The purpose of this study is to assess the benefit of vitreous surgery in preventing full-thickness macular holes in patients with impending (stage 1) macular holes. Methods: A prospective randomized multicenter clinical trial was conducted on patients with full-thickness macular holes in their first eye (stage 3 or 4) and signs and symptoms of stage 1 macular holes in their fellow eye (study eye). The study eye was randomized to vitreous surgery or observation. Outcome was assessed by standardized measurement of visual acuity, detailed clinical examination, fundus photographs, and fluorescein angiography. Results: A full-thickness macular hole developed in 10 (37%) of 27 patients in the vitrectomy group compared with 14 (40%) of 35 patients randomized to observation ( P = 0.81). This difference of 3% has a 95% confidence interval of (-21%,27%). Conclusion: The study was terminated because of low recruitment. The authors were unable to prove (or disprove) the benefit of vitreous surgery in patients with stage 1 macular holes. The authors can state, however, that should a beneficial effect from vitrectomy exist, it would probably be minimal. Considering the cost and morbidity of vitreous surgery, a conservative approach for stage 1 macular hole might be appropriate.


American Journal of Ophthalmology | 2000

Submacular surgery trials randomized pilot trial of laser photocoagulation versus surgery for recurrent choroidal neovascularization secondary to age-related macular degeneration: I. Ophthalmic outcomes. Submacular Surgery Trials Pilot Study report number 1

E Jr De Juan; Neil M. Bressler; Susan B. Bressler; P. A. Campochiaro; Julia A. Haller; Andrew P. Schachat; J. Belt; Theresa Cain; M. Hartnett; P. Hawse; Mark Herring; J. Imach; J. McDonald; T. Porter; Matthew A. Thomas; Nancy M. Holekamp; Travis A. Meredith; B. Barts; L. Breeding; J. Dahl; J. L. Gualdoni; G. Hoffmeyer; V. Nobel; E. Ort; P Jr Sternberg; A Jr Capone; Jennifer I. Lim; J. M. Brown; Deborah Gibbs; James Gilman

PURPOSE To report complications and changes in vision during 2 years of follow-up of patients with age-related macular degeneration assigned randomly to surgical removal or to laser photocoagulation of subfoveal recurrent neovascular lesions in a pilot trial designed to test methods, to refine estimates of outcome rates, and to project patient accrual rates for a larger multicenter randomized trial to evaluate submacular surgery. PATIENTS AND METHODS Eligible patients with previous laser photocoagulation of extrafoveal or juxtafoveal choroidal neovascularization secondary to age-related macular degeneration were enrolled at 15 collaborating clinical centers. Assignments to treatment arm were made by personnel at a central coordinating center. Adherence to eligibility criteria and treatment assignment was assessed centrally at a photograph reading center. Patients were examined at 3, 6, 12, and 24 months after treatment for data collection purposes. Outcome measures reported include treatment complications, adverse events, requirements for additional treatment, and 2-year changes in visual acuity from baseline. RESULTS Of 70 patients enrolled, 36 were assigned to laser photocoagulation and 34 to submacular surgery; all were treated as assigned. One patient in each group died before the 2-year examination. Visual acuity was measured at the 2-year examination for 31 of the surviving patients (89%) in the laser arm and for 28 of the surviving patients (85%) in the surgery arm. The 2-year measurements for 36 of the 59 patients (61%) were made by an examiner masked to treatment assignment and to the identity of the study eye. Improvements and losses of visual acuity were observed in both treatment arms; 20 of 31 study eyes (65%) in the laser arm and 14 of 28 study eyes (50%) in the surgery arm had visual acuity 2 years after enrollment that was better than or no more than 1 line worse than the baseline level. Changes in visual acuity and the size of the central macular lesions from baseline to the 2-year examination were similar in the treatment arms. Few serious complications were observed in either arm at the time of initial treatment; serious adverse events were rare. During follow-up, 11 laser-treated eyes and 18 surgically treated eyes had additional intraocular procedures. CONCLUSIONS The data from this pilot trial suggest no reason to prefer submacular surgery over laser photocoagulation for treatment of patients with age-related macular degeneration who have lesions similar to those studied in this pilot trial. Any clinical trial designed to compare submacular surgery with laser photocoagulation in eyes with age-related macular degeneration and subfoveal recurrent neovascular lesions must enroll several hundred patients in order to reach a statistically valid conclusion regarding differences between these two methods of treatment with respect to either changes in visual acuity or complication rates.


Ophthalmology | 1991

Idiopathic Sclerochoroidal Calcification

Arunan Sivalingam; Carol L. Shields; Jerry A. Shields; J. Arch McNamara; Lee M. Jampol; William J. Wood; Gail Daubert

Idiopathic sclerochoroidal calcification is a disorder that is often overlooked, occurring at the level of the posterior sclera and choroid in older patients. Clinically, it may be confused with choroidal osteoma, choroidal metastasis, amelanotic choroidal nevus, or choroiditis. The authors present seven cases of this unusual entity. The patients ranged in age from 58 to 80 years. In all cases, the yellow lesions were clinically estimated to be at the level of the choroid and sclera, and they were usually located superior to the superotemporal retinal vascular arcade. Systemic investigation of calcium and phosphate metabolism was normal in all patients. The classic clinical manifestations and differentiation of this unusual entity from other similar fundus lesions is discussed.


Ophthalmology | 2003

Laser treatment in fellow eyes with large drusen: Updated findings from a pilot randomized clinical trial

Maureen G. Maguire; Paul Sternberg; Thomas M. Aaberg; Daniel F. Martin; David A. Saperstein; Maureen Hyatt; James Gilman; Ray Swords; Gabriela Nemes; Lawrence J. Singerman; Thomas A. Rice; Hernando Zegarra; Michael A. Novak; Scott D. Pendergast; Z. Nicholas Zakov; John H. Niffenegger; Michelle Bartel; Susan Lichterman; Donna Knight; Kim Tilocco-DuBois; Mary Ilk; Geraldine Daley; Gregg Greanoff; John DuBois; Diane Weiss; Alice T. Lyon; Lee M. Jampol; David V. Weinberg; Beth Chiapetta; Zuzanna Strugala

PURPOSE To update the findings from the Choroidal Neovascularization Prevention Trial (CNVPT) with respect to resolution of drusen, incidence of choroidal neovascularization, and visual function. DESIGN A multicenter, randomized, controlled, pilot clinical trial. PARTICIPANTS The 120 patients enrolled in the CNVPT. Patients had signs of choroidal neovascularization or retinal pigment epithelial detachment in 1 eye and had >/=10 large (>63- micro m) drusen in the contralateral, or fellow, eye. INTERVENTION The fellow eye of 59 patients was assigned randomly to argon green laser treatment consisting of multiple 100- micro m spots at least 750 micro m from the center of the fovea. The fellow eye of the remaining 61 patients was assigned randomly to observation. MAIN OUTCOME MEASURES Change in visual acuity was the primary outcome measure. Incidence of choroidal neovascularization, resolution of drusen, change in contrast threshold, change in critical print size for reading, and incidence of geographic atrophy were secondary outcome measures. RESULTS Throughout 4 years of follow-up, there were no statistically significant differences in change in visual acuity, contrast threshold, critical print size, or incidence of geographic atrophy. With additional follow-up, the large increase in the incidence of choroidal neovascularization observed within 18 months of treatment was maintained; however, by 30 months, the incidence in the two treatment groups was the same. Most drusen resolution in treated eyes occurred within 24 months of the initial treatment. Treated eyes that received higher-intensity laser burns had an increased risk of choroidal neovascularization. Among eyes developing choroidal neovascularization in each treatment group, most lesions (two thirds or more) were composed of occult neovascularization only. CONCLUSIONS Laser treatment as applied in the CNVPT caused an excess risk of choroidal neovascularization in the first year or so after treatment. The increased early incidence of choroidal neovascularization was not associated with either a harmful or beneficial effect in this pilot study.


Retina-the Journal of Retinal and Vitreous Diseases | 2001

Locally invasive tumors arising from hyperplasia of the retinal pigment epithelium.

Jerry A. Shields; Carol L. Shields; Jason S. Slakter; William J. Wood; Lawrence A. Yannuzzi

Purpose Focal hyperplasia of the retinal pigment epithelium (RPE) is a common fundus condition that is generally stationary, with little or no tendency to enlarge or spawn neoplasms. The purpose of this report is to describe the unusual clinical features of two similar cases in which a nodular tumor of the RPE was documented to arise from a small focus of hyperplasia of the RPE. Methods Clinical and cytopathologic observations of two patients. Results Both patients were observed for approximately 25 years with an unusual progressive fundus tumor that originally arose from a small, flat, irregular focus of hyperplasia of the RPE. The originally observed pigmented lesion was attributed to toxoplasmosis in one patient and laser treatment for central serous chorioretinopathy in the other. In both patients, the tumor enlarged, invaded through the full-thickness sensory retina, and produced a characteristic retinal perforation with apposition of the mass to the vitreous. In both instances, fine-needle aspiration biopsy showed scant pigmented cells, but a definite diagnosis was not made. However, clinical observations in both patients suggested that these tumors were acquired neoplasms that arose from small foci of hyperplasia of the RPE. Conclusion Focal hyperplasia of the RPE can give rise to unusual invasive tumors that invade and replace the overlying sensory retina. These tumors have unique clinical features that differentiate them from uveal melanoma and other pigmented fundus lesions.


Ophthalmology | 1986

Sulfur and Calcific Keratophaty Associated with Retinal Detachment Surgery and Vitrectomy

Hans E. Grossniklaus; William J. Wood; C. Brent Bargeron; W. Richard Green

We report an unusual case of extensive sulfur and calcium deposition in the cornea after retinal detachment surgery, vitrectomy, and use of topical sulfacetamide. There were no signs of anterior segment ischemia and intraocular silicone oil was not used. Light and electron microscopic examination and x-ray energy dispersive analysis are described. A possible mechanism for the pathogenesis of this condition is presented.


Archives of Ophthalmology | 1993

Laser Treatment for Subfoveal Neovascular Membranes in Ocular Histoplasmosis Syndrome: Results of a Pilot Randomized Clinical Trial

Stuart L. Fine; William J. Wood; Rick D. Isernhagen; Lawrence J. Singerman; Neil M. Bressler; James C. Folk; Alan E. Kimura; Gary E. Fish; Maureen G. Maguire; Judith Alexander


Ophthalmology | 1994

Vitrectomy for Prevention of Macular Holes

Serge de Bustros; Thomas M. Aaberg; Paul Sternberg; Bert M. Glaser; Ronald G. Michels; Thomas A. Rice; Brooks W. Mc Cuen; William J. Wood; Rick D. Isernhagen; Patrick J. Murphy; H. Richard McDonald; Robert N. Johnson; Howard Schatz; R. Joseph Olk; M. Gilbert Grand; David R. Williams; Gregg T. Kokame; Jack O. Sipperley; Howard D. Gilbert; Bruce R. Garretson; Kirk H. Packo; Brian B. Berger; Cheryl Enger; William D. Freeman; Maureen G. Maguire; Andrew P. Schachat


Archives of Ophthalmology | 1995

Long-term Results of Laser Treatment in the Ocular Histoplasmosis Syndrome

Howard L. Cummings; Alan J. Rehmar; William J. Wood; Rick D. Isernhagen

Collaboration


Dive into the William J. Wood's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Brian B. Berger

University of Texas at Austin

View shared research outputs
Top Co-Authors

Avatar

Gregg T. Kokame

University of Hawaii at Manoa

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Lawrence J. Singerman

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Neil M. Bressler

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stuart L. Fine

University of Colorado Denver

View shared research outputs
Researchain Logo
Decentralizing Knowledge